Å·²©¼¯ÍÅ·ÖÏíØÖØ´ó½øÕ¹£¡½¯½¨¶«µÈÍŶÓÊ×´ÎÖ¤Ã÷¿Ú·þ»ÆÁ¬ËØ¿ÉÒÔ¸ÄÉÆÅÁ½ðÉÊϲ¡
·¢²¼Ê±¼ä£º
2021-02-28
À´Ô´£º
±½±û°±Ëá-ÀÒ°±Ëá-¶à°Í-¶à°Í°·Í¾¾¶Îª´óÄÔÌṩ¶à°Í°·¡£Ôڴ˹ý³ÌÖУ¬ÀÒ°±ËáôÇ»¯Ã¸£¨TH£©ÊÇÏÞËÙø£¬¿É½«ÀÒ°±ËáôÇ»¯²¢ÒÔËÄÇâÉúÎïµûßÊ£¨BH4£©Îª¸¨Ã¸Éú³É×óÐý¶à°Í£¨L-dopa£©¡£
2021Äê2ÔÂ24ÈÕ£¬Öйúҽѧ¿ÆÑ§Ôº/±±¾©ÐºÍҽѧԺ½¯½¨¶«£¬²ÜÑ©Ìμ°Íõçü¹²Í¬Í¨Ñ¶ÔÚSignal Transduction and Targeted Therapy£¨IF=13£©ÔÚÏß·¢±íÌâΪ“Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota”µÄÑо¿ÂÛÎÄ£¬¸ÃÑо¿±íÃ÷¿Ú·þ»ÆÁ¬ËØ£¨BBR£©¿ÉÄÜͨ¹ý¶þÇâ»ÆÁ¬ËØ£¨Ï¸¾úÏõ»¯»¹Ôø²úÉúµÄ»¹ÔÐÔBBR£©ÌṩH•²¢´Ù½øÓɶþÇâÉúÎïµûßʲúÉúµÄBH4¡£Ôö¼ÓµÄBH4ÔöÇ¿TH»îÐÔ£¬´Ó¶ø¼ÓËÙ³¦µÀϸ¾ú²úÉúL-¶à°Í¡£
¿Ú·þBBRµÄÐÐΪÀàËÆÓÚάÉúËØ¡£³¦µÀϸ¾ú²úÉúµÄ×óÐý¶à°Íͨ¹ýÑ»·½øÈë´óÄÔ£¬²¢×ª»¯Îª¶à°Í°·¡£ÎªÁËÑéÖ¤BBRµÄ×÷Óü¤»îÁ˳¦ÄÔÖᣬ½«·à³¦Çò¾úÒÆÖ²µ½ÁËÅÁ½ðÉÊϲ¡£¨PD£©Ð¡ÊóÖС£ÕâÖÖϸ¾úÏÔÖøÔö¼ÓÁËСÊóµÄÄÔ¶à°Í°·£¬¸ÄÉÆÁËPDµÄ±íÏÖ¡£ÁíÍ⣬BBRÓëϸ¾úµÄ½áºÏÏÔʾ³ö±Èµ¥¶Àϸ¾ú¸üºÃµÄÖÎÁÆÐ§¹û¡£´ËÍ⣬¶à°Í°·µÄ2,4,6-Èý¼×»ùßÁà«ËÄ·úÅðËᣨTMP-TFB£©ÑÜÉúµÄMALDI-MS³ÉÏñÈ·¶¨Á˿ڷþ³¦Çò¾úµÄСÊóÄÔÖÐÎÆ×´Ìå¶à°Í°·Ë®Æ½Éý¸ß£¬¶øBBRÔöÇ¿ÁËÄÔ¶à°Í°·µÄ³ÉÏñÇ¿¶È¡£ÕâЩ½á¹û±íÃ÷£¬BBRÊdz¦Çò¾úÖÐTHµÄ¼¤¶¯¼Á£¬²¢¿ÉÄܵ¼Ö³¦µÀÖÐL-¶à°ÍµÄ²úÉú¡£´ËÍ⣬һÏî¶Ô28λ¸ß֬Ѫ֢»¼ÕßµÄÑо¿Ö¤Êµ£¬¿Ú·þBBR¿ÉÔö¼Ó³¦µÀϸ¾úµÄѪҺ/·à±ã×óÐý¶à°Í¡£Òò´Ë£¬BBR¿ÉÄÜͨ¹ýάÉúËØÑù×÷ÓÃÉϵ÷³¦µÀ¾úȺÖÐL-¶à°ÍµÄÉúÎïºÏ³É£¬´Ó¶ø¸ÄÉÆ´óÄÔ¹¦ÄÜ¡£
³¦µÀ¾úȺÊÇÓ°Ïì´óÄÔ¹¦ÄܵĹ«ÈÏÒòËØ£¬µ«Æä»úÖÆÉв»Çå³þ¡£¶à°Í°·ÊÇÒ»ÖÖÖ÷ÒªµÄÉñ¾µÝÖÊ£¬ÆäÔÚ´óÄÔÖеÄˮƽÓëÄÔ¹¦ÄÜÃÜÇÐÏà¹Ø¡£¶à°Í°·Ö÷ÒªÔÚÄÔÉñ¾ÔªÏ¸°ûÖкϳɡ£ÔÚÈËÌåÄÚ£¬¶à°Í°·µÄÖ÷ÒªºÏ³É;¾¶ÊÇ“ L-±½±û°±ËᣨPhe£©→L-ÀÒ°±ËᣨTyr£©→£¨s£©-3,4-¶þôÇ»ù±½±û°±Ëᣨ×óÐý¶à°Í£¬L-¶à°Í→¶à°Í°·£¨Phe–Tyr–dopa–dopamine£©”µÄ´úл;¾¶¡£
Ôڴ˹ý³ÌÖУ¬µÚÒ»½×¶Î£¨Phe–Tyr²½Ö裩±»±½±û°±ËáôÇ»¯Ã¸£¨PAH£©´ß»¯£¬×ª»¯Ö÷Òª·¢ÉúÔÚ¸ÎÔàºÍÉöÔà¡£¸ÎÔࣨ»òÉöÔࣩºÍ/»òѪԴÐÔÀÒ°±ËᣨÒûʳÖУ©¿É´©¹ýѪÄÔÆÁÕϲ¢½øÈë´óÄÔ¡£Tyr-¶à°Í-¶à°Í°·×ª»¯Êǵڶþ½×¶Î£¬ÔÚ´óÄÔÖÐÓÉÀÒ°±ËáôÇ»¯Ã¸£¨TH£©ºÍ¶à°ÍÍÑôÈø£¨DDC£©Íê³É¡£¸Ã;¾¶µÄÖжϻáÒýÆðÉñ¾ÏµÍ³¼²²¡£¬ÀýÈ籽ͪÄòÖ¢ºÍÅÁ½ðÉÊϲ¡£¨PD£© £©¡£
ÀÒ°±ËáôÇ»¯Ã¸£¨TH£©ÊǶù²è·Ó°·ÉúÎïºÏ³ÉµÄÏÞËÙø£¬¿É½«L-TyrôÇ»ù»¯ÎªL-¶à°Í¡£ÀÒ°±ËáôÇ»¯Ã¸£¨TH£©ÊÇÒ»ÖÖº¬ÌúµÄµ¥¼ÓÑõø£¬ËüÐèÒªËÄÇâÉúÎïµûßÊ£¨BH4£©×÷Ϊ¸¨ÖúÒò×Ó¡£²úÉúL-¶à°Íʱ£¬BH4ת»¯Îª7,8-¶þÇâÉúÎïµûßÊ£¨BH2£©£¬Ôڴ˹ý³ÌÖÐBH4±»Á¬ÐøÏûºÄ¡£BH4¿ÉÒÔͨ¹ýÁ½ÖÖ·½Ê½ÔÚϸ°ûÖÊÖкϳɡ£ÔÚÕý³£Ìõ¼þÏ£¬BH4¿ÉÒÔÓÉGTP£¨ÄñÜÕÈýÁ×Ëᣩ-NH2P3£¨D-³àÐÍ-7,8-¶þÇâµûßÊÈýÁ×Ëᣩ –PPH4£¨6-±ûͪõ£»ùËÄÇâµûßÊ£©–BH4;¾¶ºÏ³É£¬³ÆÎª“Ô´ºÏ³É”£»ÁíÒ»·½Ã棬BH4¿ÉÒÔͨ¹ýSepaapterin→BH2→BH4µÄÐÞ¸´Í¾¾¶½øÐв¹³ä£¬¶ø¶þÇâÒ¶ËỹÔø£¨DHFR£©ÊǸºÔð½«BH2ת»¯ÎªBH4µÄ¹Ø¼üø¡£Òò´Ë£¬·¢ÏÖDHFR¼¤¶¯¼Á¿ÉÄÜÊÇÔö¼ÓBH4ˮƽºÍÔöÇ¿TH»îÐÔµÄÓÐЧ·½·¨¡£
ÒÑÔÚ³¦µÀ¾úȺÖÐ֤ʵÁ˲úÉúBH4µÄϸ¾ú£¬²¢ÇÒ΢ÉúÎïÖÐÒ²´æÔÚPhe–Tyr–dopa–dopamine´úл;¾¶¡£Õâ±íÃ÷ϸ¾ú¿ÉÄܰüº¬²¸È鶯ÎïÓÃÀ´²úÉú¶à°Í°·µÄø»ùÒòµÄͬԴÎʵ¼ÊÉÏ£¬ÓÐЩϸ¾ú¿ÉÒÔ±»ÊÓΪÉú²ú¶à°Í/¶à°Í°·µÄÉúÎï¼¼Êõ¹¤³§¡£×î½üµÄÑо¿±íÃ÷£¬³¦µÀ¾úȺ¿ÉÒÔͨ¹ý΢ÉúÎïÑÜÉúµÄ´úлÎÀýÈç5-ôÇÉ«°·£©À´µ÷½ÚÄÔ¹¦ÄÜ¡£Òò´Ë£¬¹Ø¼üµÄÎÊÌâ±ä³ÉÁËÈçºÎÒÔÒ»ÖÖʵÓõķ½Ê½À´µ÷½ÚÄÔ¹¦ÄÜ¡£
»ÆÁ¬ËØ£¨BBR£©ÊÇ´Ó²ÝÅ·²©¼¯ÍŹÙÍøÖÐÌáÈ¡µÄÌìÈ»»¯ºÏÎ·Ö×ÓÁ¿371.8£©£¬ÀýÈç»ÆÁ¬ºÍ´ÌéÞ¡£BBRÔÚÖйúÒѱ»ÓÃ×÷·Ç´¦·½Å·²©¼¯ÍŹÙÍø£¨OTC£©£¬ÓÃÓÚÖÎÁƸ¹Ðº»¼Õß¡£×Ô2004ÄêÒÔÀ´£¬Òѽ«BBR¼ø¶¨ÎªÒ»ÖÖ¾ßÓÐÐÂÓ±»úÖÆµÄ°²È«ÓÐЧµÄ¸ß֬Ѫ֢ºÍ2ÐÍÌÇÄò²¡Å·²©¼¯ÍŹÙÍøÎï¡£ÔÚ¹ýȥʮÄêÖУ¬BBR½µµÍѪ֬ºÍѪÌǵÄÁÙ´²ÁÆÐ§µÃµ½Á˹㷺֤ʵ¡£´ËÍ⣬¶ÀÁ¢µÄÑо¿Ð¡×é·´¸´±¨µÀBBR¶ÔÄÔ¹¦ÄܾßÓÐÓÐÒæ×÷Óá£
¸ÃÑо¿·¢ÏÖ¿Ú·þBBR¿Éͨ¹ý´¥·¢³¦µÀ¾úȺÖÐBH4µÄÉúÎïºÏ³É£¬Éý¸ßµÄѪҺºÍÄÔ¶à°Í/¶à°Í°·Å¨¶ÈÀ´ÔöÇ¿TH»îÐÔÒÔ²úÉúL-¶à°Í£¬²¢×îÖÕ¸ÄÉÆ¶¯ÎïµÄÉíÌå»úÄÜ¡£ÔÚÁÙ´²ÊÜÊÔÕßÖмì²â;¾¶ÖмäÌå֤ʵÁËBBR¶ÔÈËÀàµÄ×÷Óá£ÕâЩ½á¹û¿ÉÄÜΪ¿ØÖƳ¦ÓëÄÔÖ®¼äµÄ´®ÈÅÌṩеÄ˼·¡£
²Î¿¼ÏûÏ¢£ºhttps://www.nature.com/articles/s41392-020-00456-5
×ªÔØ£ºiNature΢ÐŹ«ÖÚºÅ